NEW MDLs CERTIFIED

The U.S. Judicial Panel on Multidistrict Litigation has consolidated cases in Abilify, Talc and Taxotere suits among others. The Talc litigation has been transferred to New Jersey judge Freda Wolfson.  She currently presides over Chakalos v. Johnson & Johnson, filed in November 2014 making it the most advanced suit.  New Jersey is also the home…

FDA ISSUES WARNING ABOUT SERIOUS SIDE-EFFECTS ASSOCIATED WITH FLUROQUINOLONES OUTWEIGHING THE BENEFITS

Fluroquinolones are the most popular drugs to treat mild bacterial infections, but it was not until recently that their deadly side-effects were exposed. Over 33 million Americans have taken these antibiotics annually, and of these, the most popular is Levaquin, made by the company Johnson & Johnson. Many physicians were unaware of the side-effects of…

POPULAR PAIN MED MAY CAUSE BIRTH DEFECTS

Lyrica, a widely prescribed pain medication that is heavily advertised on television may be associated with a higher risk of major birth defects.  The journal Neurology reported on the study online on May 18, 2016.  The study involved 164 women who took Lyrica during their first trimester of pregnancy.  These women were compared to a…

MS DRUG MAY BE LINKED TO COLON CANCER

A recent study published in the online issue of Neurology, the medical journal of the American Academy of Neurology indicates that the multiple Sclerosis drug mitoxantrone may be associated with an increased risk of colorectal cancer.  The drug is prescribed for aggressive types of relapsing remitting or progressive MS that don’t respond to other MS…

FDA ANTIBIOTIC WARNING

The FDA issued a safety announcement on Thursday regarding commonly prescribed antibiotics such as Cipro and Levaquin.  The announcement follows an FDA advisory panel in which 35 people testified about severe fluoroquinolone associated disability resulting from the use of Levaquin, Cipro, and Avelox. The drugs have been sold for more than 20 years and are…